This inventor holds 6 USPTO granted patents, plus 10 CIPO patents. Top assignees: Cv Therapeutics, Inc., Axys Pharmaceuticals, Inc., Other. Active years: 1999-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Carlos, CA (US) (1999)
- San Francisco, CA (US) (2004 - 2005)
- San Bruno, CA (US) (2002 - 2006)
Company Filing History:
3 out of 105 
2 out of 40 
1 out of 834,570 Years Active: 1999-2006
Title: Richard L. Mackman: Innovator in Pharmaceutical Chemistry
Introduction
Richard L. Mackman is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways. With a total of 6 patents to his name, Mackman's work has the potential to impact the treatment of various disorders.
Latest Patents
Mackman's latest patents include innovative compounds designed to inhibit cyclin-dependent kinase 2 (CDK-2) activity. These compounds are useful for treating disorders characterized by undesirable cell proliferation. His patent details a formula where specific groups are substituted to enhance the efficacy of the compounds. Another significant patent involves (hetero)aryl-bicyclic heteroaryl derivatives, which serve as protease inhibitors. These compounds have applications as anti-cancer agents and anticoagulants, providing therapeutic options for thromboembolic disorders in mammals.
Career Highlights
Throughout his career, Richard L. Mackman has worked with prominent companies in the pharmaceutical industry, including Cv Therapeutics, Inc. and Axys Pharmaceuticals, Inc. His expertise in drug development and innovation has positioned him as a key figure in the advancement of therapeutic agents.
Collaborations
Mackman has collaborated with notable professionals in his field, including Robert T. Lum and Steven R. Schow. These partnerships have contributed to the successful development of his patented inventions.
Conclusion
Richard L. Mackman is a distinguished inventor whose work in pharmaceutical chemistry continues to pave the way for new treatments. His innovative patents reflect a commitment to addressing critical health challenges through scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile